Hypersensitivity phenomena and the kidney: role of drugs and environmental agents.
Adler
S G
SG
Cohen
A H
AH
Border
W A
WA
D000818:Animals; D019867:Anti-Glomerular Basement Membrane Disease / Q000139:chemically induced; D000893:Anti-Inflammatory Agents / Q000009:adverse effects; D000906:Antibodies / Q000235:genetics / Q000276:immunology; D002216:Captopril / Q000009:adverse effects; D004342:Drug Hypersensitivity / Q000175:diagnosis / Q000209:etiology* / Q000276:immunology / Q000473:pathology; D004781:Environmental Exposure; D005921:Glomerulonephritis / Q000139:chemically induced / Q000276:immunology; D006046:Gold / Q000009:adverse effects; D003932:Heroin / Q000009:adverse effects; D006801:Humans; D006838:Hydrocarbons / Q000009:adverse effects; D006968:Hypersensitivity, Delayed / Q000503:physiopathology; D006969:Hypersensitivity, Immediate / Q000503:physiopathology; D007105:Immune Complex Diseases / Q000276:immunology / Q000503:physiopathology; D007674:Kidney Diseases / Q000139:chemically induced* / Q000276:immunology / Q000473:pathology; D007678:Kidney Glomerulus / Q000473:pathology / Q000648:ultrastructure; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced; D008628:Mercury / Q000009:adverse effects; D009395:Nephritis, Interstitial / Q000139:chemically induced / Q000276:immunology / Q000473:pathology; D010396:Penicillamine / Q000009:adverse effects; D010406:Penicillins / Q000009:adverse effects; D012293:Rifampin / Q000009:adverse effects
D000893:Anti-Inflammatory Agents; D000906:Antibodies; D006838:Hydrocarbons; D010406:Penicillins; D003932:Heroin; D006046:Gold; D002216:Captopril; D008628:Mercury; D010396:Penicillamine; D012293:Rifampin